Immuneering (IMRX) Institutional Ownership → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free IMRX Stock Alerts $1.43 -0.07 (-4.67%) (As of 04/25/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Immuneering (NASDAQ:IMRX)CurrentInstitutional OwnershipPercentage67.65%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$31.91MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.03M Get IMRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immuneering stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IMRX Institutional Buying and Selling by Quarter Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Immuneering Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2024TD Asset Management Inc197,876$1.45M0.0%-30.4%0.676% 1/5/2024 Exchange Traded Concepts LLC17,416$128K0.0%+34.0%0.060% 11/15/2023Adage Capital Partners GP L.L.C.195,000$1.50M0.0%+11.4%0.666% 11/14/2023Corton Capital Inc.18,847$145K0.1%N/A0.064% 11/13/2023Southport Management L.L.C.17,500$134K0.7%N/A0.060% 11/13/2023FMR LLC612,168$4.70M0.0%-7.0%2.092% Get the Latest News and Ratings for IMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immuneering and its competitors with MarketBeat's FREE daily newsletter. 11/13/2023PNC Financial Services Group Inc.20,000$154K0.0%N/A0.068% 10/27/2023TD Asset Management Inc284,476$2.19M0.0%+100.0%0.972% 10/18/2023 Exchange Traded Concepts LLC12,999$100K0.0%-12.7%0.044% 9/8/2023Tucker Asset Management LLC11,036$112K0.0%N/A0.038% 8/15/2023HighVista Strategies LLC253,110$2.57M1.2%N/A0.865% 8/14/2023Cormorant Asset Management LP4,204,364$42.63M2.4%+76.2%14.369% 8/11/2023ExodusPoint Capital Management LP127,719$1.30M0.0%+48.0%0.436% 8/9/2023TD Asset Management Inc142,238$1.44M0.0%-1.3%0.486% 8/4/2023American International Group Inc.9,761$99K0.0%N/A0.033% 8/2/2023Bank of Montreal Can714,037$8.00M0.0%N/A2.441% 7/26/2023Janney Montgomery Scott LLC22,135$224K0.0%N/A0.076% 7/20/2023 Exchange Traded Concepts LLC14,884$151K0.0%N/A0.051% 5/11/2023ExodusPoint Capital Management LP86,297$838K0.0%N/A0.295% 5/9/2023Y Intercept Hong Kong Ltd11,114$108K0.0%N/A0.038% 11/15/2022Citadel Advisors LLC2,184,909$31.29M0.0%-0.7%8.273% 8/4/2022TD Asset Management Inc.147,661$799K0.0%+21.8%0.560% 5/10/2022TD Asset Management Inc.121,201$784K0.0%+253.4%0.459% 2/15/2022Adage Capital Partners GP L.L.C.314,000$5.08M0.0%N/A1.210% 2/14/2022Citadel Advisors LLC2,058,102$32.04M0.0%+0.1%7.934% 2/8/2022Northern Trust Corp75,891$1.23M0.0%+4.5%0.293% 2/2/2022New York State Common Retirement Fund4,637$75K0.0%+172.8%0.018% 1/28/2022 Allspring Global Investments Holdings LLC9,228$149K0.0%N/A0.036% 12/3/2021Perceptive Advisors LLC681,051$18.08M0.3%N/A2.625% 11/16/2021Suvretta Capital Management LLC200,000$5.31M0.1%N/A0.771% 11/16/2021Metropolitan Life Insurance Co NY2,814$75K0.0%N/A0.011% 11/16/2021Millennium Management LLC89,788$2.38M0.0%N/A0.346% 11/16/2021Citadel Advisors LLC2,055,459$52.40M0.0%N/A7.924% 11/15/2021Rock Springs Capital Management LP1,089,816$28.94M0.6%N/A4.201% 11/15/2021Marshall Wace LLP13,149$349K0.0%N/A0.051% 11/15/2021Caas Capital Management LP40,000$1.06M0.0%N/A0.154% 11/12/2021Ghisallo Capital Management LLC15,000$398K0.0%N/A0.058% 11/12/2021Geode Capital Management LLC122,319$3.25M0.0%N/A0.472% 11/10/2021Citigroup Inc.1,246$33K0.0%N/A0.005% 11/9/2021BlackRock Inc.1,524,374$40.47M0.0%N/A5.877% “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).11/9/2021TD Asset Management Inc.34,296$911K0.0%N/A0.132% 11/4/2021Deutsche Bank AG4,752$126K0.0%N/A0.018% 11/2/2021New York State Common Retirement Fund1,700$45K0.0%N/A0.007% (Data available from 1/1/2016 forward) IMRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMRX shares? During the previous two years, 17 institutional investors and hedge funds held shares of Immuneering. The most heavily invested institutionals were Cormorant Asset Management LP ($42.63M), Citadel Advisors LLC ($31.29M), Bank of Montreal Can ($8.00M), FMR LLC ($4.70M), HighVista Strategies LLC ($2.57M), Adage Capital Partners GP L.L.C. ($1.50M), and TD Asset Management Inc ($1.45M).Learn more on IMRX's institutional investors. What percentage of Immuneering stock is owned by institutional investors? 67.65% of Immuneering stock is owned by institutional investors. Learn more on IMRX's institutional investor holdings. Which institutional investors have been buying Immuneering stock? Of the 15 institutional investors that purchased Immuneering stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Cormorant Asset Management LP ($1.82M), Bank of Montreal Can ($714.04K), HighVista Strategies LLC ($253.11K), TD Asset Management Inc ($142.24K), ExodusPoint Capital Management LP ($127.72K), TD Asset Management Inc. ($113.37K), and Janney Montgomery Scott LLC ($22.14K). How much institutional buying is happening at Immuneering? Institutional investors have bought a total of 3,318,346 shares in the last 24 months. This purchase volume represents approximately $32.61M in transactions. Which Immuneering major shareholders have been selling company stock? The following institutional investors have sold Immuneering stock in the last 24 months: TD Asset Management Inc ($88.47K), FMR LLC ($46.28K), Citadel Advisors LLC ($14.30K), and Exchange Traded Concepts LLC ($1.89K). How much institutional selling is happening at Immuneering? Institutional investors have sold a total of 150,926 shares in the last 24 months. This volume of shares sold represents approximately $1.23M in transactions. Related Companies: CALC Major Shareholders AADI Major Shareholders RMTI Major Shareholders BLRX Major Shareholders CKPT Major Shareholders CLNN Major Shareholders APLM Major Shareholders NXTC Major Shareholders BOLT Major Shareholders ELDN Major Shareholders This page (NASDAQ:IMRX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immuneering Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.